Clinical Trial Update: Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of MMX Mesalamine/Mesalazine in pediatric patients with mild to moderate ulcerative colitis has completed and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MMX Mesalamine/Mesalazine (mesalamine)

Snippet

Sponsor: Shire | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2020-01-18